Search results
4 wrz 2020 · Emerging SARS-CoV-2 variants and subvariants are changing the role of therapeutics. What is new? The guideline development group (GDG) defined 1.5% as a new threshold for an important reduction in risk of hospitalisation in patients with non-severe covid-19.
7 maj 2021 · Early in the COVID-19 pandemic, there was concern in the media that the use of non-steroidal anti-inflammatory drugs (NSAIDs), particularly ibuprofen, might exacerbate COVID-19 symptoms.
25 sie 2020 · Associated pain that was present before COVID-19 and may be exaggerated by a superimposed viral infection. Mild pain symptoms associated with COVID-19 can be relieved with simple analgesics such as acetaminophen and NSAIDs.
23 mar 2021 · Hydrocortisone: 50 mg intravenously every 8 hours for 10 days (0.5 ml of 100 mg/ml solution; powder for solution for injection or infusion is also available); this may be continued for up to 28 days for people with septic shock.
3 gru 2020 · Opioid use at high doses and over several months could suppress immune system function and affect the prognosis for cases of COVID-19. However, it has been suggested that immunosuppression might play a protective role during COVID-19 infection.
20 kwi 2020 · • Increase dose in 0.5-1 mg increments as required (maximum 10 mg daily, or 5 mg daily in elderly patients) • The same dose of haloperidol may be administered subcutaneously as required rather than orally, or a subcutaneous infusion of 2.5-10 mg over 24 hours • Consider a higher starting oral dose (1.5-3 mg) if the patient is severely
6 kwi 2020 · The guideline on rheumatological autoimmune, inflammatory, and metabolic bone disorders emphasises that patients with covid-19 should not stop taking their medications suddenly and should seek medical advice on whether any need to be stopped temporarily.
